Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. N Engl J Med. 2021 12 02; 385(23):2150-2160.
View in:
PubMed
subject areas
4-Hydroxycoumarins
Aged
Aged, 80 and over
Anticoagulants
Atrial Fibrillation
Factor Xa Inhibitors
Female
Gastrointestinal Hemorrhage
Humans
Intention to Treat Analysis
Kaplan-Meier Estimate
Male
Mortality
Phenindione
Postoperative Complications
Pyridines
Thiazoles
Thromboembolism
Transcatheter Aortic Valve Replacement
Vitamin K
authors with profiles
Usman Baber